ticlopidine has been researched along with Dermatomyositis in 1 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
Dermatomyositis: A subacute or chronic inflammatory disease of muscle and skin, marked by proximal muscle weakness and a characteristic skin rash. The illness occurs with approximately equal frequency in children and adults. The skin lesions usually take the form of a purplish rash (or less often an exfoliative dermatitis) involving the nose, cheeks, forehead, upper trunk, and arms. The disease is associated with a complement mediated intramuscular microangiopathy, leading to loss of capillaries, muscle ischemia, muscle-fiber necrosis, and perifascicular atrophy. The childhood form of this disease tends to evolve into a systemic vasculitis. Dermatomyositis may occur in association with malignant neoplasms. (From Adams et al., Principles of Neurology, 6th ed, pp1405-6)
| Excerpt | Relevance | Reference |
|---|---|---|
| "A clinical diagnosis of thrombotic thrombocytopenic purpura (TTP) was made." | 1.30 | A case of dermatomyositis complicated by thrombotic thrombocytopenic purpura. ( Arase, S; Horie, T; Miyaoka, Y; Nameda, Y; Sano, N; Shigekiyo, T; Urano, Y, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miyaoka, Y | 1 |
| Urano, Y | 1 |
| Nameda, Y | 1 |
| Shigekiyo, T | 1 |
| Horie, T | 1 |
| Sano, N | 1 |
| Arase, S | 1 |
1 other study available for ticlopidine and Dermatomyositis
| Article | Year |
|---|---|
A case of dermatomyositis complicated by thrombotic thrombocytopenic purpura.
Topics: Anti-Inflammatory Agents; Dermatomyositis; Dipyridamole; Dyspnea; Epoprostenol; Fatal Outcome; Fever | 1997 |